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nervous system neurons, as well as in a set of non-neu-
ronal cell types. DOPO and its derivative 6,6′-(ethane-1,2-
diylbis(azanediyl))bis(6H-dibenzo[c,e][1,2]oxaphosphin-
ine-6-oxide) (EDA-DOPO) were neither neurotoxic, nor did 
they exhibit an influence on neural crest cell migration, or 
on the integrity of human skin equivalents. The two com-
pounds furthermore displayed no inflammatory activation 
potential, nor did they affect algae growth or daphnia viabil-
ity at concentrations ≤400 µM. Based on the superior flame 
retardation properties, biophysical features suited for use in 
polyurethane foams, and low cytotoxicity of EDA-DOPO, 
our results suggest that it is a candidate for the replacement 
of currently applied flame retardants.
Keywords Flame retardants · Organophosphate · Dermal 
absorption · Neurotoxicity · Polybrominated diphenyls
Introduction
Flame retardants are added to a wide range of materials in 
order to lower the risk of uncontrolled ignition and reduce 
combustion rates. In recent years, the class of polybromi-
nated diethyl ether retardants has been phased out based 
on a growing understanding of their abundant prevalence 
in the environment and their persistence and bioaccumula-
tion in the food chain (Covaci et al. 2011; Shaw et al. 2010; 
Hites 2004). Several reports have indicated adverse effects 
of polybrominated flame retardants on endocrine functions 
mediated, for example, by thyroid-, androgen-, and estro-
gen-signaling pathways (Zhou et al. 2002; Li et al. 2013; 
Stoker et al. 2005), but also on kidney and liver integ-
rity (Albina et al. 2010), the cholinergic system (Viberg 
et al. 2002), neuronal differentiation (Dingemans et al. 
2007; Herbstman et al. 2010), and migration of neuronal 
Abstract Halogen-free organophosphorus flame retard-
ants are considered as replacements for the phased-out class 
of polybrominated diphenyl ethers (PBDEs). However, toxi-
cological information on new flame retardants is still lim-
ited. Based on their excellent flame retardation potential, we 
have selected three novel 9,10-dihydro-9-oxa-10-phospha-
phenanthrene-10-oxide (DOPO) derivatives and assessed 
their toxicological profile using a battery of in vitro test sys-
tems in order to provide toxicological information before 
their large-scale production and use. PBDE-99, applied as 
a reference compound, exhibited distinct neuro-selective 
cytotoxicity at concentrations ≥10 µM. 6-(2-((6-oxido-6H-
dibenzo[c,e][1,2]oxaphosphinin-6-yl)amino)ethoxy)-6H-
dibenzo[c,e][1,2]oxaphosphinine 6-oxide (ETA-DOPO) 
and 6,6′-(ethane-1,2-diylbis(oxy))bis(6H-dibenzo[c,e]
[1,2]oxaphosphinine-6-oxide) (EG-DOPO) displayed 
adverse effects at concentrations >10 µM in test systems 
reflecting the properties of human central and peripheral 
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precursors during development (Schreiber et al. 2010). 
Strict legal requirements regarding flammability proper-
ties are only one issue restricting the delicate choice of an 
alternative to brominated flame retardants. In addition, to 
legal issues, toxicological information plays an important 
role in protecting human safety by ensuring informed use 
of potentially harmful agents; however, such information 
is limited, while legal requirements for industry to disclose 
the chemical nature and toxicological properties of manu-
factured compounds are insufficient.
As a promising approach for the replacement of poly-
brominated diphenyl ethers that represent a major envi-
ronmental burden (Wu et al. 2012), phosphorus flame 
retardants such as inorganic red phosphorus or ammo-
nium polyphosphate, halogenated phosphorus flame 
retardants, phosphonamidates, and phosphoesters (Costa 
and Giordano 2007; van der Veen and de Boer 2012) are 
currently applied to meet regulatory flammability stand-
ards. Several of these replacements are additives and not 
covalently bound to their host material, thus allowing 
their diffusion out of the host material by volatilization, 
leaching, or mechanical abrasion (Marklund et al. 2003). 
In case of the chlorinated phosphorus flame retardant 
tris(chloropropyl)phosphate (TCPP), which was inten-
sively applied as an alternative to brominated additives, 
concentrations in the environment, indoor ambient air, and 
household dust exceed those of polybrominated diphenyl 
ethers (PBDEs; Staaf and Ostman 2005; Tollbäck et al. 
2006; van der Veen and de Boer 2012; Martínez-Carballo 
et al. 2007). Recent observations have indicated the carci-
nogenic potential of TCPP (Ni et al. 2007; WHO 1998), 
justifying concerns regarding whether the alternatives cur-
rently used actually represent a lower risk than that of the 
compounds they are supposed to replace (Behl et al. 2015). 
These safety concerns regarding the industrial applica-
tion of phosphorus flame retardants deserve considerable 
attention because structurally related phosphodiester com-
pounds, including organophosphorus pesticides, adversely 
influence the development of the nervous system and are 
used as chemical warfare agents (González-Alzaga et al. 
2014; Muñoz-Quezada et al. 2013).
One of the potential substituents, which represents the 
basis for the here introduced novel structures, is the hal-
ogen-free organophosphorus flame retardant 9,10-dihy-
dro-9-oxa-10-phosphaphenanthrene-10-oxide (DOPO), 
which displays excellent flame retardation properties and 
exhibited low acute toxicity potential in currently avail-
able studies (Waaijers et al. 2013a, b). In order to improve 
its flame retardation potential and influence its physico-
chemical parameters, such as its melting point, to allow 
industrial application in different plastic materials, novel 
phosphonamidate and phosphonate and phosphinate 
derivatives of DOPO have been developed (Gaan et al. 
2009, 2013, 2015; Buczko et al. 2014; Neisius et al. 2014; 
Salmeia and Gaan 2015; Salmeia et al. 2015), but have not 
been evaluated with respect to their toxicological poten-
tial. In the combustion process, phosphonamidate DOPO 
derivatives primarily act in the vapor phase by forming 
phosphorus-containing radical species (PO·) (Salmeia 
and Gaan 2015; Salmeia et al. 2015), which interact with 
·OH or H· radicals (Eq. 1) formed during combustion and 
therefore lead to a reduction in the release of heat, favor-
ing the extinguishing of the flame. In a subsequent step, 
the reduced phosphorus compound interacts with a second 
H· radical (or ·OH), allowing recycling of the PO· species 
(Eq. 2).
The application of such novel DOPO-derived phospho-
rus flame retardants is currently precluded by limited infor-
mation regarding their adverse effects on human develop-
ment and health. In the present study, we assessed three 
novel bis-DOPO-derived flame retardants in direct compar-
ison with their parental compound DOPO and polybromi-
nated diphenyl ether PBDE-99 with respect to their acute 
cytotoxic potential, their interaction with epidermal bar-
riers, and their influence on neuronal systems. Epidermal 
uptake was investigated by confocal Raman spectroscopy 
in ex vivo skin samples, the influence of the flame retard-
ants on epidermal architecture was investigated in a 3D 
human epidermal in vitro model, and the irritative poten-
tial of the compounds on the cellular level was analyzed 
in a keratinocyte assay allowing the quantitative detection 
of electrophilic skin-sensitizing compounds. To analyze 
the influence of the flame retardants tested herein on the 
nervous system, in vitro models of central and peripheral 
neurons were utilized. Neurons were exposed to flame 
retardants either in a fully mature state (indicator for neu-
rotoxicity) or during the differentiation process (indicator 
for developmental neurotoxicity). A potential manipulation 
of early-stage developmental processes was finally tested 
in a human in vitro neural crest cell model by which the 
influence on cell migration was assessed as readout. These 
toxicological investigations, together with a comparison 
of flame retardation properties when the compounds were 
applied as additives in polyurethane foams, indicated that 
6,6′-(ethane-1,2-diylbis(azanediyl))bis(6H-dibenzo[c,e]
[1,2]oxaphosphine-6-oxide) (EDA-DOPO) combines supe-
rior flame retardation with foaming process compatibility 
in comparison with that of DOPO; therefore, EDA-DOPO 
might emerge as a new substitute for currently applied 
flame retardants.
(1)PO· + H· → HPO
(2)2HPO+ 2H· + O2 → 2PO
·
+ 2H2O
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Materials and methods
UL94‑HB (horizontal burning) fire tests
The UL-94 (ATSM D 4986 or ISO 9772) flammability 
standard test was applied to classify the flame retardation 
potential of the organophosphorus compounds embed-
ded as additives in polyurethane (PU). The PU foam was 
cut into pieces measuring 150 mm × 50 mm × 13 mm 
(length × width × thickness). Test specimens were marked 
at 25, 60, and 125 mm. The test specimens were placed on 
an iron grid in a horizontal position above a cotton indica-
tor. A 38-mm flame was then applied to the end of the spec-
imen for 60 s. The time required to burn a 100-mm-long 
segment was recorded. The flame retardation potential of 
the test compounds was classified according to the UL-94 
horizontal flammability criteria: Classification HF 1: ≤2 s 
burning time after removal of the external flame in 80 % 
of the test specimens and ≤10 s in the remaining 20 % of 
test specimens, ≤30 s afterglow time for each individual 
specimen, <60 mm damaged length for each specimen, and 
no ignition of the cotton indicator by burning drops or par-
ticles. Classification HF 2: same criteria as HF 1 with the 
exception that the cotton is ignited by burring drops or par-
ticles. Classification HBF: burning rate ≤40 mm/min over 
a distance of 100 mm or burning length ≤125 mm. The UL 
94 horizontal rating classifications are ranked as follows: 
HF1 > HF2 > HBF > no rating.
Toxicity assessment in human alveolar epithelial cells
The human alveolar epithelial cell line A549 (ATCC: CCL-
185) was grown in Roswell Park Memorial Institute (RPMI-
1640) medium (Sigma-Aldrich) supplemented with 10 % 
FCS (Lonza), 2 mM l-glutamine (Gibco), 50 µg/mL peni-
cillin (Gibco), 50 µg/mL streptomycin (Gibco), and 100 µg/
mL neomycin (Gibco) at 37 °C in a humidified atmos-
phere containing 5 % CO2 (hereafter referred to as com-
plete cell culture medium and standard growth conditions, 
respectively). Cells were subcultured at approximately 
80–90 % confluency using 0.5 % trypsin–EDTA (Sigma-
Aldrich). For viability assessment, 1.5 × 104 cells per well 
were seeded in 200 µL complete cell culture medium in a 
96-well plate and grown overnight under standard growth 
conditions, after which the cells were treated for 48 h 
with 200 µL standard growth medium per well containing 
increasing concentrations of the flame retardants or positive 
control agent CdSO4. CellTiter96
® AQueous One Solution 
(Promega) containing MTS (3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenyl)-2H) as a 
water-soluble tetrazolium compound was used according 
to the manufacturer’s protocol. Absorption was detected at 
490 nm.
Toxicity assessment in human macrophages
The human monocytic cell line THP-1 (ATCC: TIB-202) 
was grown as cell suspension in complete cell culture 
medium under standard growth conditions. Subculturing 
was performed by replacement of the medium when the 
cell density reached 8 × 105 cells/mL. Cell concentrations 
were not allowed to exceed 106 cells/mL. To differentiate 
THP-1 monocytes into macrophages, cells were grown in 
the presence of 200 nM phorbol-12-myristate-13-acetate 
(PMA; Sigma-Aldrich) for 72 h. For viability assessment, 
8 × 104 cells per well were seeded in 200 µL complete cell 
culture medium containing 200 nM PMA in a 96-well plate 
and differentiated for 72 h under standard growth condi-
tions. Thereafter, the medium was removed, the cells were 
washed twice with pre-warmed phosphate-buffered saline 
(PBS), and increasing concentrations of flame retardants or 
CdSO4 were added in 200 µL complete cell culture medium 
per well for 48 h. CellTiter96® AQueous One Solution 
(Promega, Switzerland) containing MTS (3-(4,5-dimeth-
ylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sul-
fophenyl)-2H) as a water-soluble tetrazolium compound 
was used according to the manufacturer’s protocol. Absorp-
tion was detected at 490 nm.
3D epidermal in vitro model
Human primary keratinocytes (PR3D-HPEK-50, 
CELLnTEC, Switzerland) were grown in flasks in prolifer-
ation medium (CNT-PR, CELLnTEC) until subconfluency 
was reached, after which the cells were seeded into tran-
swell inserts containing polycarbonate membranes with a 
pore size of 0.4 µm at a density of 3.3 × 105 cells/cm2 and 
grown for 3 days in CNT-PR until confluency was reached. 
Differentiation was initiated by the addition of 3D bar-
rier medium (CNT-PR-3D, CELLnTEC) for 18 h to allow 
development of cell-to-cell adhesion structures. 3D growth 
and differentiation were induced by complete removal 
of medium from the upper transwell compartment and 
replacement of the CNT-PR-3D differentiation medium in 
the lower compartment. Cells were allowed to differentiate 
for 11 days with 3 medium changes per week in the lower 
compartment and direct cell-to-air contact in the top com-
partment. Flame retardants were suspended at a concentra-
tion of 200 mM in PBS containing 5 % DMSO, after which 
100 µL of each test compound was applied on top of the 
epithelial barrier model. Five percent SDS (sodium dode-
cyl sulfate) was used as a cytotoxic positive control com-
pound, whereas 5 % DMSO in PBS was used as a negative 
control compound. The epidermal models were treated for 
15 min at 37 °C and washed 3 times with PBS, after which 
they were further cultivated for 48 h in fresh medium. Cell 
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viability of the epidermal models was assessed by meas-
uring the reduction of resazurin to resorufin (PrestoBlue® 
Assay). Cell viability values (fluorescence signals) were 
normalized to the epidermal model thickness. Tissues were 
later washed with PBS and fixed in 10 % formalin at room 
temperature for 2.5 h. The membranes carrying the 3D epi-
dermis were removed from the transwell plates and washed 
using PBS. The 3D epidermis was dehydrated with the 
consecutive addition of: 70 % EtOH for 1 h; 96 % EtOH 
for 1 h; 96 % EtOH for 1 h, 100 % EtOH for 1 h, 100 % 
EtOH for 1 h; extraction solvent for 1 h; extraction sol-
vent for 1.5 h, paraffin for 1.5 h, paraffin for 1.5 h. Paraffin 
blocks were cut with a microtome (Zeiss, Hyrax M40) into 
5-µm slices and heated at 55 °C for 1 h. Samples were re-
hydrated in xylene and decreasing ethanol concentrations 
(2 min) and placed in water for 2 min, after which they 
were stained with hematoxylin for 15 s. After hematoxylin 
staining, the slides were “blued” by rinsing them under tap 
water (5 min) and exposing them to 75 % EtOH and 96 % 
EtOH for 2 min, after which they were stained with alco-
holic eosin (4 min). Finally, the slides were washed with 
96 % EtOH and dehydrated with 100 % EtOH and xylene. 
Samples were mounted with DPX mounting medium 
(Sigma-Aldrich) and analyzed by microscopy (Olympus IX 
81).
Skin sensitization assay
Generation of the stable KeratinoSens™ cell line was pre-
viously described in detail (Emter et al. 2010). KeratinoS-
ens™ cells were maintained in DMEM containing glu-
tamax (Gibco/Invitrogen), 9 % FCS, and 0.5 mg/mL G418. 
For the experiments, KeratinoSens™ cells were seeded 
onto 96-well plates at a density of 10,000 cells per well in 
125 µL medium without G418. After 24 h, the medium was 
replaced with 200 µL DMEM containing 1 % FCS and the 
test compounds. After a 2-day incubation period at 37 °C in 
an atmosphere containing 5 % CO2, the cells were washed 
once with PBS and a resazurin reduction assay (Presto-
Blue®) was carried out in order to compare the viability of 
the differently treated groups. Fluorescence intensity was 
measured at 550 nmex and 590 nmem. After another wash-
ing step with PBS, cell lysis was performed using 20 µL/
well passive lysis buffer (Promega) for 20 min at room 
temperature. Luciferase activity was measured by apply-
ing 50 µL luciferase substrate automatically to each well 
and detecting the resulting luminescence. Compounds were 
considered as skin sensitizers when a statistically signifi-
cant induction of luciferase activity above a defined thresh-
old of ≥1.5 in the absence of impaired cell viability was 
observed (Emter et al. 2010; Natsch et al. 2011).
Quantitative detection of flame retardants in porcine 
skin by confocal Raman spectroscopy
The vertical distribution of topically applied DOPO deriva-
tives and reference compounds was investigated on seg-
ments of porcine ears from freshly slaughtered animals. 
The skin was separated from the cartilage, depilated, and 
placed into Franz diffusion cells (1 cm2). The acceptor 
solution was PBS buffer containing 2 % IGEPAL® CA-630 
(Sigma-Aldrich). The test compounds were dispersed at a 
concentration of 400 µM (2 % in the case of caffeine) in 
PBS buffer containing 2 % IGEPAL® CA-630, after which 
300 µL of this mixture (or a blank solution) was topically 
applied onto the porcine skin and allowed to penetrate for 
60 min. Next, the skin was removed from the Franz cells, 
gently washed with PBS, and placed onto the optical win-
dow of an inverse confocal Raman microscope (Model 
3510 SCA, River Diagnostics) equipped with a 60 × oil-
immersion objective. The 785-nm excitation laser was used 
to acquire spectra in the fingerprint region (400–1800 cm−1, 
5 s integration time) starting from the surface of the skin 
and extending to a depth of 60 µm (2 µm step size). The 
acquisition was repeated for at least five positions. The 
averaged concentration profiles of the flame retardants and 
reference compounds were extracted by fitting (unrestricted 
classical least squares, third-order polynomial baseline) the 
Raman spectra with the reference spectra of keratin (as rep-
resentative of all proteins), water, ceramide 3, cholesterol 
(as representatives of all lipids), natural moisturizing fac-
tor (NMF; fixed composition), lactate, urea, and solid test 
compounds using Skin Tools 2.0 software (River Diagnos-
tics). The concentrations of the test substances are given as 
the molar fraction relative to keratin rather than correcting 
for the Raman signal attenuation using mathematical mod-
els (Franzen et al. 2013). The response factors of the test 
compounds were determined against BSA solutions assum-
ing similar Raman cross sections for keratin and BSA as 
described in the literature (Caspers et al. 2001; Fleischli 
et al. 2013, 2015). Because EDA-DOPO, ETA-DOPO, and 
EG-DOPO were only partially soluble in chloroform, their 
spectra were calibrated against DOPO with the assumption 
of the same Raman cross section for the biphenyl group. 
Because of the nature of the unrestricted fit, negative fitting 
coefficients can be obtained and the values must be com-
pared to those of the blank sample. The fitting coefficients 
of the blank, untreated skin were also used to estimate the 
level of detection. The depth resolution of the confocal 
microscope was determined to be 8 µm at FWHM, leav-
ing an uncertainty of approximately 4 µm in differentiating 
between truly permeated compounds and compounds sit-
ting at the surface of the skin.
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Toxicity assessment of central nervous system neurons
LUHMES cells are conditionally immortalized human 
fetal ventral mesencephalic neuronal precursor cells that 
were obtained by clonal selection. Differentiated LUHMES 
cells show a clear dopaminergic phenotype, which was 
described in detail previously (Schildknecht et al. 2009; 
Scholz et al. 2011). Cells were propagated in advanced 
DMEM/F12 (Gibco/Invitrogen, Darmstadt, Germany) 
with 1 × N2 supplement (Invitrogen), 2 mM l-glutamine 
(Gibco), and 40 ng/mL recombinant bFGF (R&D Systems, 
Minneapolis, MN, USA). The differentiation process was 
initiated by adding differentiation medium consisting of 
advanced DMEM/F12, 1 × N2 supplement, 2 mM l-glu-
tamine, 1 mM dibutyryl cAMP (Sigma), 1 µg/mL tetracy-
cline (Sigma), and 2 ng/mL recombinant human GDNF 
(R + D Systems). After 2 days, cells were trypsinized, col-
lected in advanced DMEM/F12 medium, and seeded onto 
24-well plates at a density of 160,000 cells/cm2. The dif-
ferentiation process was continued for 4 days. Fully differ-
entiated LUHMES cells were treated with the tested flame 
retardants for 48 h from day 6 to 8 of differentiation. For 
visualization of morphology, cells were fixed with 4 % par-
aformaldehyde for 20 min at room temperature, permeabi-
lized with 0.2 % Triton X-100, washed with PBS, blocked 
with 1 % BSA (Calbiochem, San Diego, CA, USA) in PBS 
for 1 h, and stained with a polyclonal anti-β-III-tubulin 
antibody (Sigma) in 1 % BSA/PBS at 4 °C overnight. 
After washing, secondary antibodies (anti-mouse-IgG, 
Alexa 488, Molecular Probes; 1:1000) in 1 % BSA/PBS 
were added for 1 h, after which nuclei were stained with 
Hoechst dye H-33342 (1 µg/mL) for 20 min. For visualiza-
tion, an Olympus IX 81 microscope (Hamburg, Germany) 
equipped with an F-view CCD camera was used. For quan-
titative evaluation of the neurite area, β-III-tubulin-stained 
cells were analyzed using an automated microplate-reading 
microscope (Array-Scan II® HCS Reader, Cellomics, Pitts-
burgh, PA, USA) equipped with a Hamamatsu ORCA-ER 
camera (1024 × 1024 resolution; run at 2 × 2 binning). 
Nuclei were identified according to their intensity, size, 
area, and shape. A virtual area corresponding to the cell 
soma was defined around each nucleus. The total β-III-
tubulin pixel area per field minus the soma areas in that 
field was defined as neurite mass.
Toxicity assessment of peripheral nervous system 
neurons
The human pluripotent stem cell (hPSC) line H9 (WA09 
line) was obtained from WiCell (Madison, WI, USA). 
Import of cells and experiments was authorized under 
license #170-79-1-4-27 (Robert Koch Institute, Berlin, 
Germany). Cells were cultured according to standard pro-
tocols (Thomson et al. 1998) and differentiated into dorsal 
root ganglia-like cells as described earlier (Chambers et al. 
2012), with slight modifications. Briefly, neural differentia-
tion was promoted by adding neural differentiation medium 
and the combination of 6 small molecule pathway inhibi-
tors [noggin (35 ng/mL; R&D Systems, Minneapolis, MN, 
USA), dorsomorphin (600 nM; Tocris Bioscience, Bris-
tol, UK), SB-431642 (10 μM; Tocris Bioscience, Bristol, 
UK), CHIR99021 (1.5 µM; Axon Medchem, Vienna, VA, 
USA), SU5402 (1.5 µM; Tocris Bioscience, Bristol, UK), 
and DAPT (5 µM; Merck, Darmstadt, Germany)]. The cells 
were cryopreserved on day 8′ of differentiation (DoD 8′). 
For each experiment, cells were thawed in neural differen-
tiation medium supplemented with CHIR99021 (1.5 µM), 
SU5402 (1.5 µM), and DAPT (5 µM). For the peripheral 
neurotoxicity test (PeriTox-test), test chemicals were seri-
ally diluted in differentiation medium containing BDNF, 
GDNF, and NGF (25 ng/mL; R&D Systems, Minneapolis, 
USA) and added to the cells on day 3 after thawing. After 
48 h, neurite area and viability were assessed as described 
earlier (Krug et al. 2013). Briefly, cells were loaded with 
1 µM calcein-AM and 1 µg/mL H-33342 for 1 h at 37 °C. 
For image acquisition, an Array-Scan VTI HCS (high con-
tent screening) microscope (Cellomics, Waltham, MA 
USA) was used. In an automated procedure, all H-33342+/
calcein+ cells were analyzed as viable cells. In channel 
1, H-33342+ nuclei were detected according to their size, 
area, shape, and intensity at excitation/emission wave-
lengths of 365 ± 50/535 ± 45. The nuclei borders were 
expanded radially by 3.2 µm to define a virtual cell soma 
area (VCSA). In channel 2 (at excitation/emission wave-
lengths of 474 ± 40/535 ± 45), all calcein+ pixels were 
identified as viable cell structures (VCS). An algorithm 
was applied that used the VCSA as a filter in the calcein 
channel and subtracted it from the VCS. The remaining 
pixels (VCS-VCSA) in the calcein channel were defined as 
neurite area and were represented relative to the untreated 
control.
Neural crest cell (NCC) migration assay
Human embryogenic stem cells (H9 hESC line; Wiscon-
sin International Stem Cell Bank, Madison, WI, USA) 
were plated on a confluent layer of mitomycin C-treated 
murine bone marrow-derived stromal MS5 cells and dif-
ferentiated as previously described (Lee et al. 2010; Zim-
mer et al. 2012). After 21 days, rosettes were picked and 
plated onto poly-l-ornithine/laminin/fibronectin-coated 
plates in N2 medium. After 7 days, cells were FACS-sorted 
for positive expression of the neural crest marker human 
natural killer-1 (HNK-1) and expanded in N2 medium 
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supplemented with epidermal growth factor (EGF, 20 ng/
mL) and fibroblast growth factor (FGF2, 20 ng/mL). For 
expansion, the cells were passaged every 6 days using 
accutase (PAA, Pasching, Austria) to detach the cells. After 
30 days of expansion, the cells were cryopreserved in 90 % 
fetal bovine serum, 10 % DMSO. For the analysis of neural 
crest cell migration, silicone stoppers (Platypus Technolo-
gies, Madison, WI, USA) were inserted in a 96-well plate 
coated with poly-l-ornithine/laminin/fibronectin. Freshly 
thawed NCCs were seeded at a density of 100,000 cells/
cm2 in N2 medium containing EGF and FGF2 and allowed 
to attach for 1 day. Stoppers were removed, and the cells 
were allowed to migrate into the center of the well. Com-
pounds tested in this study were diluted from a 10 mM 
stock in DMSO and were applied for 24 h. For single cell 
detection, cells were stained with H-33342 (1 µg/mL) and 
calcein-AM (0.5 µM) and imaged using a high content 
imaging microscope (Cellomics ArrayScanVTI, Thermo 
Fischer). Viability was assessed by counting the number 
of H-33342 and calcein double-positive cells outside the 
migration zone. Migration was detected by acquisition of 
the number of H-33342 and calcein double-positive cells in 
the migration area. Viability and migration were both nor-
malized to untreated controls, and DMSO concentrations 
did not exceed 1 % in all experiments.
Calculation of IC50 values
IC50 values are defined by the concentration of the flame 
retardant investigated where the response was reduced by 
half. Log-transformed flame retardant concentration val-
ues and the respective response data were fitted to a four-
parameter logistic equation:
The percent inhibition response data are represented by y; 
B = maximum of y; A = minimum of y; x = flame retard-
ant concentration; C = IC50; D = Hill slope factor. The 
IC50 values were calculated from these sigmoidal dose–
response curves utilizing Prism 5.0 (GraphPad, San Diego, 
CA, USA) software.
Statistics
Values are expressed as mean ± SD. If not otherwise indi-
cated, experiments were performed at least three times with 
three technical replicates in each experiment. Data were 
analyzed by one-way ANOVA or Student’s t test as appro-
priate. Following ANOVA, differences were determined by 




otherwise indicated, differences between means were con-
sidered statistically significant at p < 0.05.
Results
Synthesis and flame retardation properties of DOPO 
derivatives
In order to modulate the biophysical properties of DOPO 
to optimize it for use in polyurethane foams and further 
improve its flame retardation potential, three novel bis-
DOPO derivatives comprising an alkyl spacer linked via 
N-and O-atoms to the central phosphate moieties were syn-
thesized (Fig. 1a; Kobayashi et al. 2013; Gaan et al. 2013). 
The flame retardation potential was evaluated by subjecting 
the new compounds, embedded into polyurethane, to the 
UL-94 horizontal burning fire test (Fig. 1b). When added 
to soft polyurethane foams, the three novel bridged DOPO 
derivatives achieved flame retardation ratings higher than 
those of chlorophosphates TCCP and TCEP, which have 
been applied widely as reference compounds (Fig. 1b). The 
flame retardation potential of the DOPO derivatives was 
significantly higher than that of their parental compound 
DOPO (UL 94 horizontal rating classification: HF 1 > HF 
2 > HBF; Fig. 1b). The fire burning test clearly indicated 
that the novel bis-DOPO derivatives display superior flame 
retardation properties in comparison with those of the com-
pounds they are intended to replace. These features confirm 
that the novel bis-DOPO derivatives are new candidates for 
potential use in several plastic materials comprising every-
day common household goods, while raising the question 
of their adverse influence on human health.
Comparison with existing literature data
Because of their superior flame retardation potential and 
suitability for application in polyurethane foams, the three 
novel DOPO derivatives were tested in a series of in vitro 
models in order to obtain initial information on their poten-
tial harmful properties. To allow comparison with exist-
ing toxicological data for other flame retardants, DOPO 
and PBDE-99, as a representative polybrominated diethyl 
ether, were tested in parallel in all assays applied in this 
work. Inhalation is considered to be a primary route of 
exposure for flame retardants. Therefore, we first exposed 
A549 human lung epithelial cells and human macrophages 
differentiated from the THP-1 monocyte cell line to each 
flame retardant for a period of 2 days in order to assess the 
compounds acute cytotoxic potential. While DOPO, EDA-
DOPO, and PBDE-99 exhibited no signs of cell damage at 
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concentrations as high as 400 µM, ETA-DOPO and EG-
DOPO at concentrations >20 µM produced acute toxicity in 
both cell models (Fig. 2). These findings confirm observa-
tions reporting that PBDE-99 within the same concentra-
tion range used in the present study did not produce cell 
damage in A549 cells (Kim et al. 2014). Another report 
assessed DOPO toxicity in PC12 and B35 neuroblastoma 
cell models and also observed no damage using a con-
centration range comparable to that applied in the present 
study, further confirming the low cytotoxic potential of 
DOPO (Hendriks et al. 2014).
For cell types primarily involved in the inflammatory 
response, such as macrophages or astrocytes, previous 
reports indicated inflammatory activation in response to 
flame retardants (Koike et al. 2014). Therefore, we meas-
ured release of proinflammatory cytokines TNF-α and IL-8 
in differentiated THP-1 macrophages and did not observe 
significant release (Suppl. Fig. 1a + b). It was recently 
reported that PBDE-47 and PBDE-209 induce oxidative 
stress and thereby contribute to DNA damage (Pellacani 
et al. 2012). In A549 cells, no significant increase in reac-
tive oxygen species was observed (Suppl. Fig. 1c), nor were 
we able to detect DNA strand breaks in A549 or LUHMES 
cells exposed to the flame retardants tested in this work 
(Suppl. Fig. 2 + 3). As an alternative metric for the assess-
ment of inflammatory activation evoked by the tested flame 
retardants, nuclear translocation of cytosolic subunits of the 
NF-κB complex was investigated in astrocytes and, simi-
lar to the results obtained in macrophages, no effect of the 
novel flame retardants was detected (Suppl. Fig. 4).
To allow direct comparison with published DOPO toxic-
ity data in the same experimental model, the standardized 
acute daphnia immobilization (OECD guideline 202) test 
was employed. An EC50 of roughly 1.5 mM was recently 
reported for DOPO (Waaijers et al. 2013a, b). In our test-
ing of EDA-DOPO, ETA-DOPO, and EG-DOPO, even 
the highest concentrations applied (water-soluble fraction 
of a 1000 mg/L/approximately 2 mM solution) resulted 
in minimal immobilization of 5–10 % of the treated daph-
nids (Suppl. Fig. 5). In an alternative OECD-approved 
assay (OECD guideline 201), freshwater microalgae were 
exposed to the flame retardants. At the highest tested con-
centrations (water-soluble fraction of a 1000 mg/L; equal-
ling approximately a 2 mM solution), EG-DOPO inhibited 
algae growth, while EDA-DOPO and ETA-DOPO exhib-
ited no effect (Suppl. Fig. 6).
Our observations confirm the low acute toxic poten-
tial of DOPO and its derivatives in non-neuronal cells and 
lower freshwater organisms, allow a comparison of our data 
on novel DOPO derivatives with other reports, and enable 
integration of the toxicological data presented herein into 
the network of data in the literature.
Fig. 1  a Structures of 9,10-dihydro-9-oxa-10-phosphaphenanthrene-
10-oxide (DOPO) and novel bridged DOPO derivatives EDA-DOPO, 
ETA-DOPO, and EG-DOPO. The derivatives are characterized by 
variations in the heteroatom attached to the phosphorus center of the 
DOPO monomer, comprising two phosphate moieties (EG-DOPO), 
two phosphoramidate moieties (EDA-DOPO), or a combination of 
phosphate and phosphoramidate moieties. b UL-94 horizontal burn-
ing fire test. The flame retardants were added to polyurethane foam 
at the indicated concentrations. The concentration in the host material 
was based on the weight of the polyol used in the manufacturing pro-
cess of polyurethane foam. The density of the polyurethane foam was 
approximately 50 kg/m3. Based on the inherent reactivity of DOPO, 
its final concentration in the foam was limited to 5 %. UL-94 hori-
zontal rating classification: HF 1 > HF 2 > HBF > no rating. TCPP 
(tris(2-chloroisopropyl)phosphate) and TCEP (tris-(2-chloroethyl)
phosphate) were included in the fire tests as representative examples 
of widely applied chlorophosphates
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Interaction of DOPO derivatives with epidermal 
barriers
Dermal uptake of flame retardants present in ambient air 
and household dust, as well as by direct contact with plastic-
containing materials, has emerged as a major uptake route in 
addition to ingestion and inhalation. To assess the effects of 
the novel flame retardants on the integrity of the skin, three 
different models were applied. For an analysis of the acute 
damage of the epidermal architecture, a 3D human in vitro 
epidermal model was utilized, in which samples were topi-
cally exposed to the respective flame retardant for 15 min at 
a concentration of 200 mM. Even at the highest concentra-
tions applied to the stratum corneum, all tested flame retard-
ants displayed no detectable influence on the architecture of 
the epidermis (Fig. 3a). Positive control compound 5 % SDS 
resulted in complete disintegration of the stratum corneum 
and substantial cell death in the stratum spinosum. The viabil-
ity of the epidermal models was assessed using the Presto-
Blue® assay, which indicated no significant changes follow-
ing exposure to the flame retardants (data not shown). The 
observed absence of significant epidermal damage could be 
the result of negligible penetration of the compounds into 
the epidermis or a consequence of epidermal cells having 
high resistance in comparison with that of other cell types. 
To assess penetration into a complex skin structure, the flame 
retardants were next applied topically to segments of porcine 
ears from freshly slaughtered animals. Uptake was detected 
in a noninvasive manner by application of confocal Raman 
spectroscopy (Fig. 3b). Caffeine was used as a positive con-
trol compound. The assays indicated significant accumula-
tion of ETA-DOPO at the skin surface and moderate accu-
mulation of PBDE-99 into porcine ear skin, while all other 
compounds displayed no detectable penetration into the skin 
within the investigated time period of 1 h.
Assessment of the flame retardants sensitization 
potential
In order to assess the skin-sensitizer potential of the flame 
retardants when in direct contact with epidermal cells, a 
keratinocyte-based cell model optimized to detect elec-
trophilic skin-sensitizing compounds was utilized. With 
this keratinocyte-based model, covalent modifications of 
active site cysteine residues in Keap1 by electrophiles 
lead to its dissociation from Nrf2, which subsequently 
Fig. 2  Determination of acute cytotoxicity. Human alveolar epithe-
lial cells (A549) and human monocytes (THP-1) differentiated into 
macrophages were treated with the flame retardants for 48 h. Viability 
was assessed by measuring reduction of the tetrazolium compound 
MTS. All data are mean ± SD (n = 3); *p < 0.05
◂
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Fig. 3  Interaction of DOPO 
derivatives with epidermal 
barriers. a Influence of flame 
retardants on epidermal integ-
rity. The air-exposed stratum 
corneum of a 3D epidermal 
in vitro model generated from 
primary human keratinocytes 
was topically treated with vari-
ous flame retardants (200 mM) 
for 15 min. The models were 
washed and further cultivated 
for 48 h. The tissues were 
analyzed by a viability assay 
and then fixed, sliced, and 
stained with hematoxylin and 
eosin to allow discrimination 
of epidermal layers. The loose 
layer beneath the stratum basale 
represents the filter membrane. 
b Penetration of flame retard-
ants into skin. For the assess-
ment of quantitative penetra-
tion profiles, porcine skin was 
topically exposed to the flame 
retardants (400 µM) for 1 h. 
Confocal Raman microscopy 
was applied to obtain a depth 
profile for each compound. The 
graph illustrates the amount of 
each flame retardant and that 
of positive control compound 
caffeine relative to keratin 
content as a function of depth. 
c Keratinocyte sensitization. To 
determine the skin sensitization 
potential of the tested flame 
retardants, KeratinoSens™ cells 
were stimulated with different 
concentrations of DOPO deriva-
tives. Luciferase activity was 
detected 48 h after treatment, 
and the fold induction was 
calculated. Benzylidene acetone 
served as a positive control 
treatment. In parallel, the viabil-
ity of the cells was assessed 
using the PrestoBlue® reduction 
assay. All data are mean ± SD 
(n = 3); *p < 0.05
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accumulates in the nucleus and activates expression of 
genes with an antioxidant response element (ARE) in their 
promoter (Emter et al. 2010). Treatment of the reporter 
construct-carrying keratinocytes with the flame retard-
ants revealed an increase in ARE-dependent luciferase 
expression following exposure to ETA-DOPO and EG-
DOPO that was inversely correlated with a decline in cell 
viability. Under the experimental conditions employed 
in Fig. 3c, the increased strength of the luciferase signal 
cannot be attributed to a specific innate response of the 
cells, but must rather be interpreted as a consequence of 
cell death-associated processes. Comparable effects were 
observed with higher concentrations (>10 µM) of the pos-
itive control compound benzylidene acetone. However, 
PBDE-99 led to a concentration-dependent and moder-
ate increase in ARE-dependent luciferase expression 
(ca. twofold increase at a concentration of 3 µM) in the 
absence of significant cell death, thus indicating the skin 
sensitization potential of PBDEs. DOPO and EDA-DOPO 
neither induced luciferase activity nor adversely affected 
cell viability (Fig. 3c), in agreement with the results 
shown in Fig. 2, which were obtained with human lung 
cells and macrophages. Taken together, these observations 
confirmed the cytotoxic potential of ETA-DOPO and EG-
DOPO in 2D cell models.
Based on the assays applied herein, the tested flame 
retardants do not appear to have a direct adverse influence 
on epidermal integrity. There are also no reports indicating 
a direct degenerative influence of flame retardants present in 
household dust on human skin. More importantly, however, 
is the fact that some of the compounds have the potential 
to penetrate the stratum corneum and thus enter the human 
body. Our observations of DOPO derivative penetration 
were limited to only 1 h. Whereas uptake of ETA-DOPO 
and PBDE-99 was apparent even after this short incubation 
period, these experiments cannot exclude the possibility that 
DOPO, EDA-DOPO, and EG-DOPO might penetrate the 
skin and enter the human body under conditions of chronic 
interaction.
Toxicity of flame retardants in central nervous system 
neurons
Previous studies on the toxicity of halogenated flame 
retardants identified a wide spectrum of different cell 
types and organs affected by exposure to such com-
pounds, but they explicitly highlighted the adverse effects 
of halogenated flame retardants on neuronal integrity and 
neurodevelopmental processes (Hendriks et al. 2014). To 
investigate the influence of DOPO derivatives on fully dif-
ferentiated central nervous system neurons, we exposed 
human LUHMES cells, which were differentiated into 
mature post-mitotic neurons within a period of 6 days 
(Schildknecht et al. 2009; Scholz et al. 2011). Fully dif-
ferentiated LUHMES cells (day 6) were subsequently 
treated with varying concentrations of each flame retard-
ant (Fig. 4a) for a period of 2 days (days 6–8; Fig. 4b). 
To visualize cell morphology, treated cells were fixed and 
stained with an anti-β-III-tubulin antibody. In our previ-
ous studies with LUHMES cells, we observed that neur-
ite architecture served as a far more sensitive marker for 
neuronal integrity than did classical cell viability assays 
(Krug et al. 2013; Schildknecht et al. 2013). For the quan-
titative assessment of total neurite mass, an automated 
microscope system with an analysis algorithm allowing 
the detection of total neurite mass was applied (Fig. 4c). 
In addition, cell viability was detected by measuring the 
reduction of resazurin and by the lactate dehydrogenase 
(LDH) release assay, as well as by detecting intracellu-
lar levels of ATP and reduced glutathione (GSH) (Supp. 
Fig. 7). In summary, all assays indicated degeneration of 
neurites evoked by ETA-DOPO, EG-DOPO, and PBDE-
99 at concentrations >10 µM, while DOPO and EDA-
DOPO exhibited no influence at concentrations as high as 
100 µM. These results were obtained with fully differen-
tiated neurons. To investigate the influence of the flame 
retardants on neurite outgrowth when present during the 
differentiation process, LUHMES cells were treated from 
day 0 to day 2 of their differentiation period (Suppl. Fig. 8 
and 9) that is characterized by the outgrowth of neurites. 
In the absence of acute cytotoxic effects, changes in neu-
rite outgrowth are considered as a developmental neuro-
toxicity parameter. Qualitatively, the observations made 
in developing cells were the same as those made in fully 
differentiated cells, with the exception that EDA-DOPO 
also revealed a moderate, but significant influence on 
total neurite area. However, this effect was not reflected 
by intracellular levels of ATP and GSH, which served as 
cell viability markers (Suppl. Fig. 8 and 9). In order to 
introduce an alternative assay to investigate more subtle 
changes in neurite integrity, we investigated the migration 
of mitochondria in neurites of differentiated LUHMES 
cells (Suppl. Fig. 10). Treatment of the cells with the par-
kinsonian toxin MPP+, applied herein as a positive con-
trol compound, resulted in a significant decline in the 
velocity of mitochondrial migration in neurites, while 
all flame retardants exhibited no significant influence on 
mitochondrial migration under conditions where neurite 
integrity was not affected (25 µM, 12 h; Suppl. Fig. 10). 
At high concentrations, ETA-DOPO, EG-DOPO, and 
PBDE-99 influenced mitochondrial velocity; however, 
this effect was directly correlated with neurite degenera-
tion and thus cannot be considered as an independent tox-
icity parameter.
Analysis of neurite mass and integrity in differentiat-
ing and mature LUHMES cells as neuro-selective readout 
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and the comparison with results obtained by the resazurin 
reduction or LDH release assays as general cell viability 
markers, indicated that the tested flame retardants did not 
evoke neuro-specific degeneration. Instead, the observed 
impact on neurites could rather be considered as a conse-
quence of general cell degenerative processes.
Fig. 4  Toxicity in neurons of 
the central nervous system. a 
Mature human dopaminergic 
neurons (LUHMES) were 
treated with the flame retard-
ants for 48 h from day 6 to day 
8 of LUHMES differentiation 
as indicated in scheme (b). Cell 
morphology was visualized 
by fixation and staining of the 
cells with an anti-β-III-tubulin 
antibody (yellow), whereas 
nuclear DNA was stained with 
Hoechst dye H-33342 (blue). c 
For quantitative assessment of 
total neurite mass, cells were 
analyzed using an automated 
microscope system with an 
imaging algorithm that allowed 
cell bodies and cell extensions 
to be distinguished. The graph 
shows the total neurite mass 
detected following the respec-
tive treatments. All data are 
mean ± SD (n = 3); *p < 0.05
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Toxicity of flame retardants in neurons of the 
peripheral nervous system
Neurons of the central nervous system (CNS) are protected 
by the blood-brain barrier. Therefore, it may be speculated 
that neurons of the peripheral nervous system represent a 
more vulnerable target because of their more direct expo-
sure to environmental toxicants in vivo, in addition to 
intrinsic features distinguishing them from CNS neurons. 
To assess potential differences between central and periph-
eral neurons with respect to their responses to the tested 
flame retardants, we generated peripheral neurons from 
Fig. 5  Toxicity in neurons of the peripheral nervous system. a Dif-
ferentiation scheme for the generation of human dorsal root ganglia-
like cells. The pluripotent stem cell line hESC-H9 was differentiated 
into peripheral neurons in a 2-step scheme. b Flame retardants were 
applied at day of differentiation (DoD) 3 post-thawing for a period of 
48 h, after which neurite outgrowth was investigated by staining the 
cells with calcein-AM (cell morphology) and Hoechst dye H-33342 
(nuclei). c Quantitative assessment of cell number and neurite mass 
was conducted with an automated microscope system. Image analy-
sis was performed with optimized algorithms that allowed cells to 
be counted by counting nuclei. Neurite growth was quantitatively 
assessed by detection of the entire calcein signal subtracted from a 
defined area surrounding the nucleus, which was defined as the cell 
body. Data are mean ± SEM (n = 3); *p < 0.05
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human stem cell-derived neural precursors and treated 
them with each flame retardant for 48 h (Fig. 5a). Similar 
to the observations made in CNS neurons, EG-DOPO and 
PBDE-99 significantly affected neurite integrity (Fig. 5b) 
and cell viability (Fig. 5c), while DOPO, EDA-DOPO, and 
ETA-DOPO moderately affected neurite mass and reduced 
cell viability at concentrations >50 µM. These observations 
indicate that no significant difference between central and 
peripheral neurons exists in vitro with respect to their dam-
age in response to the tested flame retardants. Although 
we did not investigate the mechanisms underlying cell 
death, the parallel decline in neurite mass and cell viability 
observed in central and peripheral neurons, together with 
the comparable responses of non-neuronal cells (Figs. 2, 
3), suggests that DOPO and its derivatives evoke a cell 
type-independent mechanism of cell damage.
Influence of flame retardants on neural crest cell 
migration
The adverse effects of a compound on the nervous system 
are not necessarily correlated with its direct toxicity or its 
influence on neuronal differentiation. Even subtle changes 
in neural precursor migration during early development can 
profoundly influence the subsequent development of the 
nervous system. Therefore, we tested the flame retardants 
in a stem cell-derived human neural crest cell migration 
assay (Fig. 6). Cells were allowed to migrate into a cell-
free area, as illustrated in Fig. 6a, after which migration 
and cell viability on the individual cell level were assessed. 
While DOPO and EDA-DOPO inhibited neither cell migra-
tion nor cell viability, ETA-DOPO and EG-DOPO both 
produced concentration-dependent declines in cell migra-
tion and cell viability (Fig. 6b). PBDE-99 moderately, but 
significantly, inhibited cell migration, but did not reduce 
Fig. 6  Influence of flame retardants on neural crest cell migration. 
a Neural crest cells were differentiated from the human embry-
onic stem cell line hESC-H9. The two images of control- and EG-
DOPO-treated cells illustrate the general principle of the assay. The 
area inside the imaginary dotted ring was covered in the beginning 
of the experiment by silicone inserts, while the cells were seeded 
into the surrounding area. Following removal of the inserts, cells 
were allowed to migrate into the cell-free area. For the delineation 
and identification of single cells, nuclei were stained with Hoechst 
dye H-33342 (blue), whereas cell bodies were stained with calcein 
(green). For better visualization, areas of blue and green overlay are 
depicted in red. b Detection of migration and cell viability. Following 
removal of the stoppers, cells were allowed to migrate in the presence 
of the flame retardants for 24 h. The number of cells within the imag-
inary ring was counted and compared with the number of cells in the 
entire well to assess the contribution of cell proliferation events. Via-
bility was detected by comparison of the number of calcein-positive 
cells with the total number of cells in the well. Data are mean ± SD 
(n = 3); *p < 0.05
▸
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cell viability. Similar effects were observed with ETA-
DOPO and EG-DOPO in a relatively narrow concentration 
range of approximately 30–60 µM, in which migration was 
far more affected by these flame retardants in comparison 
with cell viability. This indicates an adverse effect of these 
compounds on early developmental processes. In all neu-
ronal assays, ETA-DOPO and EG-DOPO showed cytotoxic 
properties at significantly lower concentrations than did 
DOPO and EDA-DOPO.
Comparison and prioritization of organophosphorus 
flame retardants
In the present work, several in vitro test systems for the 
assessment of the potential adverse effects of the three novel 
DOPO derivatives were implemented. To allow a better 
comparison between the safety profiles of the tested com-
pounds, the IC50 values determined by these assays were 
plotted in a single graph (Fig. 7). Because of the limited sol-
ubility of the compounds at maximal residual DMSO lev-
els of 0.1 %, the maximal concentration in two-dimensional 
cell culture experiments was limited to 400 µM. Within this 
concentration range, some assays displayed no reduction in 
viability, precluding calculation of IC50 values. In all assays 
utilized, EDA-DOPO exhibited no harmful effects, while 
the average IC50 values of ETA-DOPO and EG-DOPO were 
in the range of 20–100 µM in all applied models. The three 
novel DOPO derivatives tested in the present work all exhib-
ited superior flame retardation potential in comparison with 
that of their parental compound DOPO. The present initial 
analysis showed the cell damaging potential of ETA-DOPO 
and EG-DOPO within a concentration range comparable to 
that at which PBDE-99 produces toxicity. EDA-DOPO dis-
played flame retardation superior to that of its parental com-
pound DOPO and evoked no harmful effects in any assay 
employed in this work.
Discussion
Acute toxicity of DOPO derivatives in context 
with current literature data
In the present work, the potential harmful influence of novel 
halogen-free bis-DOPO compounds linked via alkyl spac-
ers by N- and O-bonds was assessed for the first time using 
a set of cellular in vitro assays. The three novel compounds 
were designed in order to possess improved flame retar-
dation potential, but also for a wide range of applications 
based on their higher melting points and increased stabil-
ity, which are prerequisites for their use in the production 
of plastic materials (Buczko et al. 2014; Gaan et al. 2013, 
2015; Neisius et al. 2014; Salmeia and Gaan 2015; Salmeia 
et al. 2015; Qiang et al. 2011). In contrast to the current 
practice of investigating the potential harmful properties of 
flame retardants after their introduction into the market, we 
applied here a series of human in vitro screening assays to 
allow a fundamental toxicological classification before the 
production and application of halogen-free bis-DOPO com-
pounds on an industrial scale. In contrast with the vast lit-
erature on polybrominated diethyl ethers, covering aspects 
such as indoor and outdoor contamination levels, human 
uptake routes, accumulation in different organs and tissues, 
and toxic effects in a variety of in vitro and in vivo test 
systems (Watkins et al. 2011; Stapleton et al. 2014; Lyche 
et al. 2015; Liagkouridis et al. 2015), only limited data on 
DOPO toxicity, and no information on the harmful influ-
ence of bis-DOPO derivatives, are available.
In order to allow a direct comparison of the toxico-
logical data presented in this study with published data on 
polybrominated diphenyls, the parental compound DOPO 
and PBDE-99, as a representative PBDE, were incorpo-
rated in all experiments. At concentrations up to 400 µM, 
DOPO displayed no influence on all parameters investi-
gated herein. These findings verify data from a previous 
study by Hendriks et al., in which rat adrenomedullary 
pheochromocytoma PC12 cells and rat neuroblastoma B35 
cells that were treated for 24 h with the maximal concen-
tration of 100 µM DOPO exhibited no signs of alterations 
in cell viability, generation of reactive oxygen species, or 
intracellular Ca2+ levels (Hendriks et al. 2014). In a stand-
ardized daphnia immobilization assay (OECD Guidelines 
Fig. 7  Synopsis of IC50 values. The plot summarizes the IC50 values 
obtained from the assays applied in this work. In the in vitro assays, 
maximal flame retardant concentrations were limited to 400 µM 
because of the maximal residual DMSO concentration of 0.1 %. 
Because of this limitation, IC50 values were not calculated for some 
compounds. The calculated IC50 values are illustrated on the lower 
segment of the plot. The data points at the top of the plot indicate that 
clear toxicity was not observed at test concentrations of 100–400 µM. 
n.d. not determined
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for the Testing of Chemicals, Test No. 202), treatment 
of young daphnids with the water-soluble fraction of a 
1000 mg/L suspension (approximately 2 mM) of DOPO 
for 48 h did not significantly influence viability (Waaijers 
et al. 2013a, b). Our toxicological assessment of the three 
bis-DOPO compounds with the same standardized daph-
nia model revealed no significant influence at any con-
centration applied (water-soluble fraction of a 1000 mg/L 
suspension; Suppl. Fig. 5). Based on this information, we 
applied DOPO as a negative control reference compound in 
our experiments to allow direct comparison with currently 
available data and to enable integration of the information 
generated in the present work into the existing network of 
toxicological data on flame retardants. PBDE-99, a repre-
sentative polybrominated diphenyl compound, was chosen 
as a positive control. Among the vast number of PBDE 
variants produced, five congeners, PBDE-47, PBDE-99, 
PBDE-100, PBDE-153, and PBDE-154, predominate in 
human tissues and account for more than 90 % of PBDEs 
detected in the human body (Stasinska et al. 2014). The 
reported absence of adverse effects by PBDE-99 in non-
neuronal cells at concentrations up to 100 µM was con-
firmed by our observations made with A549 cells, THP-1 
cells, and keratinocytes (Figs. 2, 3). However, epidemio-
logical investigations focusing on the relationship between 
PBDE exposure in early development and deficits in psy-
chomotor and IQ performance in later life indicated a pro-
found influence of PBDE-99 on the development and func-
tion of the neuronal system (Shy et al. 2011; Gump et al. 
2014; Herbstman et al. 2010; Chevrier et al. 2010; Chao 
et al. 2011). Our observation of the selective influence of 
PBDE-99 on central and peripheral neuronal integrity was 
fundamentally supported by other reported in vitro obser-
vations indicating pronounced selective toxicity in neuronal 
cells (Schreiber et al. 2010). These observations clearly 
indicate that the cell type-selective toxicity of PBDEs is 
adequately represented by the in vitro models employed in 
the present study. Combined with the observations made 
with DOPO, which served as the negative control com-
pound in our work, the information on the toxicological 
response to PBDE-99 allows direct comparison with the 
relatively large number of in vitro observations in the lit-
erature. Data on PBDEs in the literature allow some cor-
relation between their toxicity in cell culture in vitro sys-
tems, their levels in different human organs and tissues, and 
their adverse effects on psychomotor functions in humans. 
Under the assumption of comparable volatilization rates 
and bioaccumulation properties of PBDEs and bis-DOPO 
compounds, the data presented herein allow preliminary 
speculation on the potential interference of bis-DOPO 
compounds with neurodevelopmental processes in vivo, 
which should be addressed by utilizing in vivo test models 
to compile an adverse effect profile of these compounds.
Comparison of in vitro and in vivo flame retardant 
burdens
Toxicological results obtained with in vitro models raise the 
question of actual in vivo concentrations in humans, which 
are largely influenced by the biophysical properties of a 
given compound. Comprehensive literature on indoor and 
outdoor contamination levels and organ and tissue accumu-
lation rates is currently available for PBDEs. Several stud-
ies analyzing PBDE levels in cohorts in various countries 
have been published in recent years (Chao et al. 2007; Roze 
et al. 2009; Eskenazi et al. 2013). Exposure of infants to 
PBDEs has been routinely observed as significantly higher 
than that of adults, largely as a result of higher rates of 
oral, nasal, and dermal uptake, as well as of different toxi-
cokinetic parameters (Toms et al. 2009; Rose et al. 2010). 
PBDE-99 was identified in office dust at concentrations of 
approximately 900 ng/g dust (Watkins et al. 2013). While 
uptake of house dust by adults was found to be in the 
range of 20–50 mg/day, that of smaller children was found 
to reach 100–200 mg/day (Wilford et al. 2005; U.S. EPA 
2008). For children, this rate of dust uptake implies a daily 
uptake of PBDE-99 in the range of 75 ng/day. Based on 
the lipophilicity of PBDEs and their ability to pass the pla-
cental barrier, breastfed infants are exposed to a daily oral 
dose of PBDE congeners approximately 300-fold higher 
than that to which adults are exposed (Toms et al. 2009; 
Rose et al. 2010; Costa et al. 2014). Average blood levels 
of PBDEs in adults in the USA have been reported in the 
range of 10–300 ng/g lipid, whereas the reported infant 
blood levels of PBDEs were almost an order of magnitude 
greater (Costa and Giordano 2007; Toms et al. 2009; Rose 
et al. 2010). Assuming a uniform distribution of PBDEs in 
the blood, these numbers equate to a steady-state PBDE 
concentration in the range of 10–100 nM in the blood 
(Costa et al. 2014). Considering their lipophilicity, accumu-
lation of PBDEs in lipid-rich tissues such as the brain, kid-
neys, liver, and fat can easily lead to local concentrations in 
the low micromolar range, which is similar to the range of 
concentrations tested in this work.
Epidermal uptake of organophosphorus flame 
retardants and evaluation of sensitization effects
The primary routes of flame retardant uptake have been 
generally considered to be ingestion and inhalation. How-
ever, recent pharmacokinetic calculations indicate that der-
mal uptake represents the second most important contribu-
tor to the PBDE body burden, exceeded only by uptake via 
ingestion (Abdallah et al. 2015). DOPO and its bis-DOPO 
derivatives are additives and thus are not covalently bound 
to their host material, implying an inherent tendency for 
volatilization. Considering their primary use in plastic 
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materials used in everyday consumer products such as 
household appliances and furniture, dermal contact with 
DOPO derivatives is an important health concern follow-
ing their introduction onto the market. We therefore inves-
tigated the influence of DOPO derivatives on the integrity 
of a three-dimensional in vitro epidermal model, as well 
as their sensitization potential and cytotoxicity when in 
contact with cultured keratinocytes. Apical application 
of flame retardants at concentrations of up to 200 mM (in 
DMSO) resulted in no apparent disintegration of the epi-
dermal architecture. The stratum corneum represents the 
outermost layer of the epidermis and consists of nucleus- 
and organelle-free corneocytes that are constantly replaced 
by desquamation. Direct contact of the flame retardants 
with the stratum corneum apparently had no influence on 
its integrity (Fig. 3a), but evoked the question of the influ-
ence of the flame retardants when in contact with organelle-
containing cells of the stratum granulosum or stratum spi-
nosum. In order to address this question, we first analyzed 
the depth to which apically applied flame retardants can 
penetrate an intact epidermis. Analysis by Raman micros-
copy indicated detectable accumulation of ETA-DOPO 
and to a lesser extent of PBDE-99 at the porcine skin sur-
face with a maximal penetration depth of less than 8 µm. 
Human stratum corneum has a typical thickness of 17 µm, 
while the thickness in pigs is 21–26 µm (Godin and Toui-
tou 2007). These findings indicate that penetration of exter-
nally applied flame retardants can be efficiently deferred 
by the stratum corneum; however, the incubation interval 
employed in Fig. 3b was limited to only 1 h, which con-
trasts with the chronic exposure of humans to flame retard-
ants under everyday conditions. The assessment of the 
toxicity of EDA-DOPO, ETA-DOPO, and EG-DOPO in a 
two-dimensional keratinocyte cell culture model revealed 
IC50 values (Fig. 3c) for the flame retardants that were 
comparable to our observations in macrophages and lung 
epithelial cells (Fig. 2). In order to evaluate whether the 
flame retardants may act as sensitizers on human skin, the 
KeratinoSens™ assay that primarily assesses the reaction 
of compounds with cysteine residues was performed. No 
specific effects that would classify DOPO, EDA-DOPO, 
ETA-DOPO, or EG-DOPO as sensitizers were apparent. 
These high concentrations applied in this work are rather 
unlikely to occur by exposure to ambient air and household 
dust. Furthermore, in a living organism, penetrated com-
pounds are continuously distributed by the vascular system. 
By taking these considerations into account, it can be con-
cluded that the direct harmful influence of the flame retard-
ants tested in this study on epithelial barriers is likely to be 
negligible. However, the observed import of extracorporeal 
flame retardants via the skin apparently represents a poten-
tial route for their uptake, which is an essential parameter 
in the evaluation of their safety profile.
Neurotoxic potential of DOPO derivatives
Studies on the harmful potential of polybrominated flame 
retardants highlighted their explicit adverse influence on 
the neuronal system (Costa and Giordano 2007; Costa et al. 
2014). Exposure of test animals to PBDEs during early 
development slowed motor skill development, influenced 
synaptic plasticity, and altered hippocampal long-term 
potentiation in rats and mice (Viberg et al. 2006; Ding-
emans et al. 2007; Ta et al. 2011). Recent human epidemio-
logical studies confirmed the relationship between exposure 
to PBDEs during early development and reduced psycho-
motor development, motor function, and IQ in childhood 
(Chevrier et al. 2010; Herbstman et al. 2010; Chao et al. 
2011; Gump et al. 2014). Plasma levels of PBDEs detected 
in these studies were usually not associated with acute neu-
rodegenerative events. However, early brain development is 
characterized by phases of precursor proliferation, migra-
tion, and differentiation that are tightly regulated spatially 
and temporally. Therefore, it can be assumed that moder-
ate interference by environmental toxicants during early 
brain development might lead to miswiring of neuronal cir-
cuits or changes in the ratios of different neuronal types. 
Such an effect would lead to increased levels of particular 
neurotransmitters and reduced levels of others, as shown 
by inhibitory effects on the cholinergic system, which is 
involved in learning and memory (Viberg et al. 2003).
Based on the literature, we applied a series of in vitro test 
systems to study the potential harmful influence of organo-
phosphate flame retardants on the integrity of differentiated 
and differentiating neurons of the central and peripheral 
nervous system, as well as their influence on NCC migra-
tion. In our previous studies on in vitro neurodegeneration, 
we utilized quantitative assessment of total neurite mass 
and migration of mitochondria in neurites as metrics with 
greatly improved sensitivity in comparison with that of 
standard cytotoxicity assays such as resazurin reduction, 
MTT reduction, or the LDH release assay. Interestingly, 
neurite integrity and mitochondrial migration occurred in 
a concentration- and time-dependent manner that closely 
reflected the decline in central and peripheral neuron via-
bility detected by resazurin reduction, LDH release, and 
uptake of calcein-AM (Figs. 4, 5; Suppl. Fig. 10). Fur-
thermore, the concentration-dependent toxicity evoked 
by ETA-DOPO and EG-DOPO in the neuronal models 
occurred at a lower concentration range than that which 
produced toxicity in the non-neuronal models (Figs. 2, 3). 
In both models of central and peripheral nervous system 
neurons, comparable profiles of cell damage and toxicity 
were observed in fully differentiated cells and differentiat-
ing cells (Fig. 4; Suppl. Fig. 7, 8, and 9). In contrast, and 
in agreement with previous reports, PBDE-99 exhibited 
distinct neurotoxic effects and detrimentally influenced 
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central and peripheral neurons at concentrations >10 µM, 
while the compound produced no significant toxicity in 
non-neuronal models such as macrophages, lung epithe-
lial cells, and keratinocytes at concentrations as high as 
400 µM. These findings clearly illustrate that DOPO and its 
derivatives possess a cell type-independent toxicity profile. 
Previous reports on the damage evoked by PBDEs in the 
nervous system highlight their influence on neuronal differ-
entiation and neural precursor cell migration (Zimmer et al. 
2014). Inappropriate migration of precursor cells in early 
brain development would entail significant disturbance in 
neuronal function. DOPO and EDA-DOPO influenced nei-
ther NCC migration nor NCC viability at concentrations as 
high as 100 µM. ETA-DOPO and EG-DOPO affected cell 
viability in a concentration range identical to that used to 
obtain the results shown in Figs. 2, 3, 4, and 5. Interest-
ingly, in contrast with the effects of PBDE-99 on differen-
tiating and fully differentiated central and peripheral neu-
rons (Figs. 4, 5), PBDE-99 did not reduce the viability of 
human NCCs at concentrations as high as 100 µM (Fig. 6). 
However, migration of NCCs was inhibited by PBDE-99. 
These observations fully corroborate the findings of a pre-
vious report utilizing NCCs (Zimmer et al. 2014), in which 
PBDE-99 inhibited migration in the absence of cell death at 
concentrations as high as 100 µM. An investigation of the 
selective neurotoxicity of PBDE-99 was outside the scope 
of the present work; however, the data provided herein and 
in the literature indicate an interaction of PBDE-99 with 
neuro-selective targets that are expressed after the migra-
tion of immature neurons to their ultimate position in the 
brain, but before neurite outgrowth is inhibited.
Conclusion
The present work represents the first toxicological assess-
ment of DOPO derivatives EDA-DOPO, ETA-DOPO, 
and EG-DOPO with an explicit focus on cellular in vitro 
models. The comparison with PBDE-99 as a representa-
tive polybrominated diphenyl ether convincingly dem-
onstrated that ETA-DOPO and EG-DOPO possess cell 
type-independent cytotoxic properties at concentrations 
>10 µM, while DOPO and EDA-DOPO display no compa-
rable effects at concentrations higher than 100 µM, as can 
be deduced from the graphical summary of all IC50 values 
calculated from the experiments reported herein (Fig. 7). 
The information provided herein allows targeted design of 
in vivo experiments addressing questions regarding uptake, 
distribution, and accumulation of DOPO derivatives in 
organs and tissues, as well as their influence on develop-
mental processes. Combination of the present in vitro data 
with in vivo observations in test animals would provide 
a solid platform for a qualified initial assessment of the 
adverse potential of DOPO derivatives EDA-DOPO, ETA-
DOPO, and EG-DOPO in humans.
Acknowledgments The study was supported by grants from the 
Land Baden Württemberg, BMBF, RTG1331, KoRS-CB, and Mem-
osystems. The DOPO derivatives were developed as a part of SUS-
PUR, EUREKA project. We are thankful to CTI Switzerland and 
Foampartner, Fritz Nauer AG, Switzerland, for their financial and 
technical support. We are also thankful to Dr. Daniel Rentsch, Empa, 
for his support for NMR measurements and analysis. We gratefully 
thank Andreas Natsch (Givaudan, Switzerland) for providing the 
KeratinoSens™ cell line to the ZHAW. We furthermore thank Xenia 
Mäder-Althaus and Laura Nel for excellent technical support.
Compliance with ethical standards 
Conflict of interest The authors declare that they have no conflict 
of interest.
Open Access This article is distributed under the terms of the 
Creative Commons Attribution 4.0 International License (http://crea-
tivecommons.org/licenses/by/4.0/), which permits unrestricted use, 
distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were 
made.
References
Abdallah MA, Pawar G, Harrad S (2015) Evaluation of in vitro vs. 
in vivo methods for assessment of dermal absorption of organic 
flame retardants: a review. Environ Int 74:13–22
Albina ML, Alonso V, Linares V, Bellés M, Sirvent JJ, Domingo 
JL, Sánchez DJ (2010) Effects of exposure to BDE-99 on oxi-
dative status of liver and kidney in adult rats. Toxicology 
271(1–2):51–56
Behl M, Hsieh JH, Shafer TJ, Mundy WR, Rice JR, Boyd WA, Freed-
man JH, Hunter ES, Jarema K, Padilla S, Tice RR (2015) Use 
of alternative assays to identify and prioritize organophosphorus 
flame retardants for potential developmental and neurotoxicity. 
Neurotoxicol Teratol 52(Pt B):181–193
Buczko A, Stelzig T, Bommer L, Rentsch D, Heneczkowski M, Gaan 
S (2014) Bridged DOPO derivatives as flame retardants for PA6. 
Poly Degrad Stab 107:158–165
Caspers P, Lucassen G, Carter E, Bruining H, Puppels G (2001) In 
vivo confocal Raman microspectroscopy of the skin: noninvasive 
determination of molecular concentration profiles. J Invest Der-
matol 116(3):434–442
Chambers SM, Qi Y, Mica Y, Lee G, Zhang XJ, Niu L, Bilsland J, 
Cao L, Stevens E, Whiting P, Shi SH, Studer L (2012) Combined 
small-molecule inhibition accelerates developmental timing and 
converts human pluripotent stem cells into nociceptors. Nat Bio-
technol 30(7):715–720
Chao HR, Wang SL, Lee WJ, Wang YF, Päpke O (2007) Levels of 
polybrominated diphenyl ethers (PBDEs) in breast milk from 
central Taiwan and their relation to infant birth outcome and 
maternal menstruation effects. Environ Int 33(2):239–245
Chao HR, Tsou TC, Huang HL, Chang-Chien GP (2011) Levels of 
breast milk PBDEs from southern Taiwan and their potential 
impact on neurodevelopment. Pediatr Res 70(6):596–600
Chevrier J, Harley KG, Bradman A, Gharbi M, Sjödin A, Eskenazi B 
(2010) Polybrominated diphenyl ether (PBDE) flame retardants 
and thyroid hormone during pregnancy. Environ Health Perspect 
118(10):1444–1449
424 Arch Toxicol (2017) 91:407–425
1 3
Costa LG, Giordano G (2007) Developmental neurotoxicity of poly-
brominated diphenyl ether (PBDE) flame retardants. Neurotoxi-
cology 28(6):1047–1067
Costa LG, de Laat R, Tagliaferri S, Pellacani C (2014) A mechanistic 
view of polybrominated diphenyl ether (PBDE) developmental 
neurotoxicity. Toxicol Lett 230(2):282–294
Covaci A, Harrad S, Abdallah MA, Ali N, Law RJ, Herzke D, de 
Wit CA (2011) Novel brominated flame retardants: a review of 
their analysis, environmental fate and behaviour. Environ Int 
37(2):532–556
Dingemans MM, Ramakers GM, Gardoni F, van Kleef RG, Bergman 
A, Di Luca M, van den Berg M, Westerink RH, Vijverberg HP 
(2007) Neonatal exposure to brominated flame retardant BDE-47 
reduces long-term potentiation and postsynaptic protein levels in 
mouse hippocampus. Environ Health Perspect 115(6):865–870
Emter R, Ellis G, Natsch A (2010) Performance of a novel keratino-
cyte-based reporter cell line to screen skin sensitizers in vitro. 
Toxicol Appl Pharmacol 245(3):281–290
Eskenazi B, Chevrier J, Rauch SA, Kogut K, Harley KG, Johnson C, 
Trujillo C, Sjödin A, Bradman A (2013) In utero and childhood 
polybrominated diphenyl ether (PBDE) exposures and neurode-
velopment in the CHAMACOS study. Environ Health Perspect 
121(2):257–262
Fleischli F, Mathes S, Adlhart C (2013) Label free non-invasive imag-
ing of topically applied actives in reconstructed human epider-
mis by confocal Raman spectroscopy. Vib Spectrosc 68:29–33
Fleischli FD, Morf F, Adlhart C (2015) Skin concentrations of topi-
cally applied substances in reconstructed human epidermis 
(RHE) compared with human skin using in vivo confocal Raman 
microscopy. Chimia 69(3):147–151
Franzen L, Selzer D, Fluhr J, Schaefer U, Windbergs M (2013) 
Towards drug quantification in human skin with confocal Raman 
microscopy. Eur J Pharm Biopharm 84(2):437–444
Gaan S, Rupper P, Salimova V, Heuberger M, Rabe S, Vogel F (2009) 
Thermal decomposition and burning behavior of cellulose treated 
with ethyl ester phosphoramidates. Effect of alkyl substituent on 
nitrogen atom. Polym Degrad Stab 94:1125–1134
Gaan S, Neisius M, Mercoli P, Liang S, Mispreuve H, Naescher R 
(2013) Phosphonamidates, production methods and flame retard-
ant applications. Patent WO2013020696 A2 
Gaan S, Liang S, Mispreuve H, Perler H, Naescher R, Neisius M 
(2015) Flame retardant flexible polyurethane foams from 
novel DOPO-phosphonamidate additives. Polym Degrad Stab 
113:180–188
Godin B, Touitou E (2007) Transdermal skin delivery: predictions 
for humans from in vivo, ex vivo and animal models. Adv Drug 
Deliver Rev. 59(11):1152–1161
González-Alzaga B, Lacasaña M, Aguilar-Garduño C, Rodríguez-
Barranco M, Ballester F, Rebagliato M, Hernández AF (2014) 
A systematic review of neurodevelopmental effects of prenatal 
and postnatal organophosphate pesticide exposure. Toxicol Lett 
230(2):104–121
Gump BB, Yun S, Kannan K (2014) Polybrominated diphenyl ether 
(PBDE) exposure in children: possible associations with cardio-
vascular and psychological functions. Environ Res 132:244–250
Hendriks HS, Meijer M, Muilwijk M, van den Berg M, Westerink RH 
(2014) A comparison of the in vitro cyto- and neurotoxicity of 
brominated and halogen-free flame retardants: prioritization in 
search for safe(r) alternatives. Arch Toxicol 88(4):857–869
Herbstman JB, Sjödin A, Kurzon M, Lederman SA, Jones RS, Rauh 
V, Needham LL, Tang D, Niedzwiecki M, Wang RY, Perera F 
(2010) Prenatal exposure to PBDEs and neurodevelopment. 
Environ Health Perspect 118(5):712–719
Hites RA (2004) Polybrominated diphenyl ethers in the environment 
and in people: a meta-analysis of concentrations. Environ Sci 
Technol 38(4):945–956
Kim JS, Klösener J, Flor S, Peters TM, Ludewig G, Thorne PS, Rob-
ertson LW, Luthe G (2014) Toxicity assessment of air-delivered 
particle-bound polybrominated diphenyl ethers. Toxicology 
317:31–39
Kobayashi J, Ishikawa A, Miwa K, Iguchi S (2013) Flame retarder 
comprising condensed phosphonic acid ester and flame-retardant 
resin composition. Patent WO 2013015376
Koike E, Yanagisawa R, Takigami H, Takano H (2014) Penta- and 
octa-bromodiphenyl ethers promote proinflammatory protein 
expression in human bronchial epithelial cells in vitro. Toxicol In 
Vitro 28(2):327–333
Krug A, Balmer N, Matt F, Schonenberger F, Merhof D, Leist M 
(2013) Evaluation of a human neurite growth assay as spe-
cific screen for developmental neurotoxicants. Arch Toxicol 
87(12):2215–2231
Lee G, Chambers SM, Tomishima MJ, Studer L (2010) Derivation of 
neural crest cells from human pluripotent stem cells. Nat Protoc 
5(4):688–701
Li X, Gao Y, Guo LH, Jiang G (2013) Structure-dependent activities 
of hydroxylated polybrominated diphenyl ethers on human estro-
gen receptor. Toxicology 309:15–22
Liagkouridis I, Cousins AP, Cousins IT (2015) Physical-chemi-
cal properties and evaluative fate modelling of ‘emerging’ 
and ‘novel’ brominated and organophosphorus flame retard-
ants in the indoor and outdoor environment. Sci Total Environ 
524–525:416–426
Lyche JL, Rosseland C, Berge G, Polder A (2015) Human health risk 
associated with brominated flame-retardants (BFRs). Environ Int 
74:170–180
Marklund A, Andersson B, Haglund P (2003) Screening of organo-
phosphorus compounds and their distribution in various indoor 
environments. Chemosphere 53(9):1137–1146
Martínez-Carballo E, González-Barreiro C, Sitka A, Scharf S, 
Gans O (2007) Determination of selected organophosphate 
esters in the aquatic environment of Austria. Sci Total Environ 
388(1–3):290–299
Muñoz-Quezada MT, Lucero BA, Barr DB, Steenland K, Levy K, 
Ryan PB, Iglesias V, Alvarado S, Concha C, Rojas E, Vega C 
(2013) Neurodevelopmental effects in children associated with 
exposure to organophosphate pesticides: a systematic review. 
Neurotoxicology 39:158–168
Natsch A, Bauch C, Foertsch L, Gerberick F, Normann K, Hilberer A, 
Inglis H, Landsiedel R, Onken S, Reuter H, Schepky A, Emter 
R (2011) The intra- and inter-laboratory reproducibility and pre-
dictivity of the KeratinoSens assay to predict skin sensitizers 
in vitro: results of a ring-study in five laboratories. Toxicol In 
Vitro 25(3):733–744
Neisius M, Lutz M, Rentsch D, Hemberger P, Gaan S (2014) Synthe-
sis of DOPO-based phosphonamidates and their thermal proper-
ties. Ind Eng Chem Res 53:2889–2896
Ni Y, Kumagai K, Yanagisawa Y (2007) Measuring emissions of 
organophosphate flame retardants using a passive flux sampler. 
Atmos Environ 41:3235–3240
Pellacani C, Buschini A, Galati S, Mussi F, Franzoni S, Costa LG 
(2012) Evaluation of DNA damage induced by 2 polybrominated 
diphenyl ether flame retardants (BDE-47 and BDE-209) in SK-
N-MC cells. Int J Toxicol 31(4):372–379
Qiang Y, Mack GA, Junzuo W (2011) Process for the preparation of 
DOPO-derived compounds and composition thereof. Patent WO 
2011123389 A1
Rose M, Bennett DH, Bergman A, Fängström B, Pessah IN, Hertz-
Picciotto I (2010) PBDEs in 2-5 year-old children from Califor-
nia and associations with diet and indoor environment. Environ 
Sci Technol 44(7):2648–2653
Roze E, Meijer L, Bakker A, Van Braeckel KN, Sauer PJ, Bos 
AF (2009) Prenatal exposure to organohalogens, including 
425Arch Toxicol (2017) 91:407–425 
1 3
brominated flame retardants, influences motor, cognitive, and 
behavioral performance at school age. Environ Health Perspect 
117(12):1953–1958
Salmeia KA, Gaan S (2015) An overview of some recent advances in 
DOPO-derivatives: chemistry and flame retardant applications. 
Polym Degrad Stab 113:119–134
Salmeia KA, Fage J, Liang S, Gaan S (2015) An overview of mode of 
action and analytical methods for evaluation of gas phase activi-
ties of flame retardants. Polymers 7(3):504–526
Schildknecht S, Pöltl D, Nagel DM, Matt F, Scholz D, Lotharius J, 
Schmieg N, Salvo-Vargas A, Leist M (2009) Requirement of a 
dopaminergic neuronal phenotype for toxicity of low concentra-
tions of 1-methyl-4-phenylpyridinium to human cells. Toxicol 
Appl Pharmacol 241(1):23–35
Schildknecht S, Karreman C, Pöltl D, Efrémova L, Kullmann C, Gut-
bier S, Krug A, Scholz D, Gerding HR, Leist M (2013) Gen-
eration of genetically-modified human differentiated cells for 
toxicological tests and the study of neurodegenerative diseases. 
ALTEX 30(4):427–444
Scholz D, Pöltl D, Genewsky A, Weng M, Waldmann T, Schildknecht 
S, Leist M (2011) Rapid, complete and large-scale generation of 
post-mitotic neurons from the human LUHMES cell line. J Neu-
rochem 119(5):957–971
Schreiber T, Gassmann K, Götz C, Hübenthal U, Moors M, Krause G, 
Merk HF, Nguyen NH, Scanlan TS, Abel J, Rose CR, Fritsche 
E (2010) Polybrominated diphenyl ethers induce developmental 
neurotoxicity in a human in vitro model: evidence for endocrine 
disruption. Environ Health Perspect 118(4):572–578
Shaw SD, Blum A, Weber R, Kannan K, Rich D, Lucas D, Koshland 
CP, Dobraca D, Hanson S, Birnbaum LS (2010) Halogenated 
flame retardants: do the fire safety benefits justify the risks? Rev 
Environ Health 25(4):261–305
Shy CG, Huang HL, Chang-Chien GP, Chao HR, Tsou TC (2011) 
Neurodevelopment of infants with prenatal exposure to poly-
brominated diphenyl ethers. Bull Environ Contam Toxicol 
87(6):643–648
Staaf T, Ostman C (2005) Organophosphate triesters in indoor envi-
ronments. J Environ Monit 7(9):883–887
Stapleton HM, Misenheimer J, Hoffman K, Webster TF (2014) Flame 
retardant associations between children’s handwipes and house 
dust. Chemosphere 116:54–60
Stasinska A, Heyworth J, Reid A, Callan A, Odland JØ, Trong Duong 
P, Van Ho Q, Hinwood A (2014) Polybrominated diphenyl ether 
(PBDE) concentrations in plasma of pregnant women from 
Western Australia. Sci Total Environ 493:554–561
Stoker TE, Cooper RL, Lambright CS, Wilson VS, Furr J, Gray LE 
(2005) In vivo and in vitro anti-androgenic effects of DE-71, a 
commercial polybrominated diphenyl ether (PBDE) mixture. 
Toxicol Appl Pharmacol 207(1):78–88
Ta TA, Koenig CM, Golub MS, Pessah IN, Qi L, Aronov PA, Ber-
man RF (2011) Bioaccumulation and behavioral effects of 
2,2′,4,4′-tetrabromodiphenyl ether (BDE-47) in perinatally 
exposed mice. Neurotoxicol Teratol 33(3):393–404
Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, 
Marshall Vand J, Jones M (1998) Embryonic stem cell lines 
derived from human blastocysts. Science 282(5391):1145–1147
Tollbäck J, Tamburro D, Crescenzi C, Carlsson H (2006) Air sam-
pling with Empore solid phase extraction membranes and online 
single-channel desorption/liquid chromatography/mass spec-
trometry analysis: determination of volatile and semi-volatile 
organophosphate esters. J Chromatogr A 1129(1):1–8
Toms LM, Sjödin A, Harden F, Hobson P, Jones R, Edenfield E, Muel-
ler JF (2009) Serum polybrominated diphenyl ether (PBDE) 
levels are higher in children (2–5 years of age) than in infants 
and adults. Environ Health Perspect 117(9):1461–1465
U.S. EPA (2008) Chiled-specific exposure factors handbook (final 
report). U.S. EPA, Ed. U.S. Environmental Protection Agency, 
Washington, DC
van der Veen I, de Boer J (2012) Phosphorus flame retardants: proper-
ties, production, environmental occurrence, toxicity and analysis. 
Chemosphere 88(10):1119–1153
Viberg H, Fredriksson A, Eriksson P (2002) Neonatal exposure to the 
brominated flame retardant 2,2′,4,4′,5-pentabromodiphenyl ether 
causes altered susceptibility in the cholinergic transmitter system 
in the adult mouse. Toxicol Sci 67(1):104–107
Viberg H, Fredriksson A, Jakobsson E, Orn U, Eriksson P (2003) 
Neurobehavioral derangements in adult mice receiving decabro-
minated diphenyl ether (PBDE 209) during a defined period of 
neonatal brain development. Toxicol Sci 76(1):112–120
Viberg H, Johansson N, Fredriksson A, Eriksson J, Marsh G, Eriks-
son P (2006) Neonatal exposure to higher brominated diphenyl 
ethers, hepta-, octa-, or nonabromodiphenyl ether, impairs spon-
taneous behavior and learning and memory functions of adult 
mice. Toxicol Sci 92(1):211–218
Waaijers SL, Bleyenberg TE, Dits A, Schoorl M, Schütt J, Kools SA, 
de Voogt P, Admiraal W, Parsons JR, Kraak MH (2013a) Daph-
nid life cycle responses to new generation flame retardants. Envi-
ron Sci Technol 47(23):13798–13803
Waaijers SL, Hartmann J, Soeter AM, Helmus R, Kools SA, de Voogt 
P, Admiraal W, Parsons JR, Kraak MH (2013b) Toxicity of new 
generation flame retardants to Daphnia magna. Sci Total Environ 
463–464:1042–1048
Watkins DJ, McClean MD, Fraser AJ, Weinberg J, Stapleton HM, 
Sjödin A, Webster TF (2011) Exposure to PBDEs in the office 
environment: evaluating the relationships between dust, hand-
wipes, and serum. Environ Health Perspect 119(9):1247–1252
Watkins DJ, McClean MD, Fraser AJ, Weinberg J, Stapleton HM, 
Webster TF (2013) Associations between PBDEs in office air, 
dust, and surface wipes. Environ Int 59:124–132
WHO (1998) Environmental Health Criteria 209. International Pro-
gram on Chemical Safety. World Health Organization, Geneva
Wilford BH, Shoeib M, Harner T, Zhu J, Jones KC (2005) Poly-
brominated diphenyl ethers in indoor dust in Ottawa, Canada: 
implications for sources and exposure. Environ Sci Technol 
39(18):7027–7035
Wu J, Zhang Y, Luo X, She Y, Yu L, Chen S, Mai B (2012) A review 
of polybrominated diphenyl ethers and alternative brominated 
flame retardants in wildlife from China: levels, trends, and bioac-
cumulation characteristics. J Environ Sci 24(2):183–194
Zhou T, Taylor MM, DeVito MJ, Crofton KM (2002) Developmental 
exposure to brominated diphenyl ethers results in thyroid hor-
mone disruption. Toxicol Sci 66(1):105–116
Zimmer B, Lee G, Balmer NV, Meganathan K, Sachinidis A, Studer 
L, Leist M (2012) Evaluation of developmental toxicants and 
signaling pathways in a functional test based on the migra-
tion of human neural crest cells. Environ Health Perspect 
120(8):1116–1122
Zimmer B, Pallocca G, Dreser N, Foerster S, Waldmann T, Wester-
hout J, Julien S, Krause KH, van Thriel C, Hengstler JG, Sachi-
nidis A, Bosgra S, Leist M (2014) Profiling of drugs and envi-
ronmental chemicals for functional impairment of neural crest 
migration in a novel stem cell-based test battery. Arch Toxicol 
88(5):1109–1126
